Schönenberg an der Thur, Switzerland 13.02.2025

TB Farming AG is pleased to announce a strategic partnership with Sabores Púrpura, Lda. This partnership will allow TB Farming to cultivate medical cannabis under an existing license in Portugal. Sabores Púrpura, Lda provides its regulatory approved license covering the cultivation, production, wholesale, import and export of cannabis for medicinal purposes.

This agreement gives TB Farming access to a production capacity of up to 44 tons of THC-containing medicinal cannabis per year. Production is carried out in accordance with the strict requirements of Good Agricultural and Collection Practice (GACP) and meets the highest pharmaceutical standards. Plans to expand the site. TB Farming AG plans to further develop the site and build a modern cultivation and production infrastructure to meet the growing demand for high-quality medicinal cannabis in Europe.

Sustainable production and compliance with regulatory standards

The partnership with Sabores Púrpura, Lda ensures that all cultivation and production processes comply with international regulatory requirements. Thanks to TB Farming’s many years of expertise in the production of high-quality medicinal cannabis, a consistently high product quality can be guaranteed at very economical prices.

“This cooperation is a decisive milestone for TB Farming and consolidates our efforts to supply the European market with first-class medical cannabis. By gaining access to an established license, we can optimally contribute our expertise in the cultivation and production of high-quality medical cannabis products and provide sustainable support to the European healthcare market,” explains Mike Toniolo, CEO of TB Farming AG.

Strategic advantages of the partnership

The collaboration between TB Farming and Sabores Púrpura offers a number of strategic advantages:

• Regulatory security
  Use of an approved license for the cultivation and distribution of medicinal cannabis in Europe.
• Safety
  Production and development take place in one of the safest countries in the world, which ensures long-term stability and reliable framework conditions for sustainable growth.
• High production capacity
  Annual cultivation of up to 44,000 kilograms of medicinal cannabis.
• Location advantage
  Ideal climatic conditions for the cultivation of high-quality cannabis.
• Pharmaceutical quality
  Compliance with GACP standards to ensure product quality.

Future prospects

With this partnership, TB Farming is taking a decisive step towards sustainable premium cannabis production for the medical sector in Europe.
Over the coming months, the company will advance the construction of the production facility in Portugal, working closely with the relevant authorities and partners to ensure compliance with all legal and quality requirements. The growing demand for medical cannabis, particularly with recent developments in Germany, highlights the long-term relevance of this collaboration. TB Farming is committed to ensuring a continuous supply of high-quality products for the European market to meet increasing demand in the long term.